| INBS Stock | | | USD 1.61 0.10 6.62% |
Intelligent Bio financial indicator trend analysis is infinitely more than just investigating Intelligent Bio Solutions recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Intelligent Bio Solutions is a good investment. Please check the relationship between Intelligent Bio Total Stockholder Equity and its Long Term Debt accounts. Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intelligent Bio Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in bureau of labor statistics.
Total Stockholder Equity vs Long Term Debt
Total Stockholder Equity vs Long Term Debt Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Intelligent Bio Solutions Total Stockholder Equity account and
Long Term Debt. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Intelligent Bio's Total Stockholder Equity and Long Term Debt is -0.52. Overlapping area represents the amount of variation of Total Stockholder Equity that can explain the historical movement of Long Term Debt in the same time period over historical financial statements of Intelligent Bio Solutions, assuming nothing else is changed. The correlation between historical values of Intelligent Bio's Total Stockholder Equity and Long Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Stockholder Equity of Intelligent Bio Solutions are associated (or correlated) with its Long Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Long Term Debt has no effect on the direction of Total Stockholder Equity i.e., Intelligent Bio's Total Stockholder Equity and Long Term Debt go up and down completely randomly.
Correlation Coefficient | -0.52 |
| Relationship Direction | Negative |
| Relationship Strength | Very Weak |
Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.
Long Term Debt
Long-term debt is a debt that Intelligent Bio Solutions has held for over one year. Long-term debt appears on Intelligent Bio Solutions balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Intelligent Bio Solutions balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.
Most indicators from Intelligent Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Intelligent Bio Solutions current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intelligent Bio Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in bureau of labor statistics.
At this time, Intelligent Bio's
Enterprise Value Over EBITDA is comparatively stable compared to the past year.
Enterprise Value Multiple is likely to gain to 0.30 in 2024, whereas
Selling General Administrative is likely to drop slightly above 4.9
M in 2024.
Intelligent Bio fundamental ratios Correlations
Click cells to compare fundamentals
Intelligent Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Intelligent Bio fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Intelligent Stock Analysis
When running Intelligent Bio's price analysis, check to
measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to
predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.